Data on BiP and Sigma1R chaperones in clinical and experimental studies of Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and Huntington’s disease are presented. Here, SIGMAR1 is linked to early-onset autosomal dominant Alzheimer disease.